Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALOGLIPTIN\METFORMIN Cause Sars-cov-2 test positive? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Sars-cov-2 test positive have been filed in association with ALOGLIPTIN\METFORMIN. This represents 3.2% of all adverse event reports for ALOGLIPTIN\METFORMIN.

12
Reports of Sars-cov-2 test positive with ALOGLIPTIN\METFORMIN
3.2%
of all ALOGLIPTIN\METFORMIN reports
0
Deaths
12
Hospitalizations

How Dangerous Is Sars-cov-2 test positive From ALOGLIPTIN\METFORMIN?

Of the 12 reports, 12 (100.0%) required hospitalization.

Is Sars-cov-2 test positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALOGLIPTIN\METFORMIN. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does ALOGLIPTIN\METFORMIN Cause?

Off label use (35) Diarrhoea (34) Pneumonia (24) Pemphigoid (19) Disease recurrence (18) Drug ineffective (17) Hypertension (17) Lactic acidosis (17) Tonsil cancer (16) Blood pressure increased (15)

What Other Drugs Cause Sars-cov-2 test positive?

OCRELIZUMAB (1,421) ADALIMUMAB (1,301) DUPILUMAB (860) NIRMATRELVIR\RITONAVIR (538) LENALIDOMIDE (469) SECUKINUMAB (378) CERTOLIZUMAB PEGOL (361) RISANKIZUMAB-RZAA (335) RITUXIMAB (305) UPADACITINIB (281)

Which ALOGLIPTIN\METFORMIN Alternatives Have Lower Sars-cov-2 test positive Risk?

ALOGLIPTIN\METFORMIN vs ALOGLIPTIN\PIOGLITAZONE ALOGLIPTIN\METFORMIN vs ALOSETRON ALOGLIPTIN\METFORMIN vs ALPELISIB ALOGLIPTIN\METFORMIN vs ALPHA.-LIPOIC ACID ALOGLIPTIN\METFORMIN vs ALPHA.-TOCOPHEROL

Related Pages

ALOGLIPTIN\METFORMIN Full Profile All Sars-cov-2 test positive Reports All Drugs Causing Sars-cov-2 test positive ALOGLIPTIN\METFORMIN Demographics